Literature DB >> 11032895

Cocaine and methamphetamine differentially affect opioid peptide mRNA expression in the striatum.

D H Adams1, G R Hanson, K A Keefe.   

Abstract

In general, administration of methamphetamine and cocaine alters preprodynorphin and preproenkephalin mRNA levels in striatum. However, no study has directly compared the effects of these stimulants on opioid peptides in striatum. This study used in situ hybridization to compare directly the effects of cocaine and methamphetamine on preprodynorphin and preproenkephalin mRNAs in distinct striatal regions. Male Sprague-Dawley rats received a single administration of 15 mg/kg methamphetamine or 30 mg/kg cocaine and were killed 30 min or 3 h later. Methamphetamine and cocaine differentially affected preprodynorphin mRNA in striatum after 3 h. Densitometric analysis of film autoradiograms revealed that cocaine, but not methamphetamine, significantly increased preprodynorphin. This effect was seen throughout rostral striatum and dorsally in caudal striatum. However, specific analysis of "patches" in which preprodynorphin expression is high revealed a significantly greater effect of methamphetamine versus cocaine. In contrast, both cocaine and methamphetamine had similar effects on preproenkephalin mRNA, decreasing levels after 30 min in rostral striatum and in the core of nucleus accumbens. These data suggest that methamphetamine and cocaine have distinct postsynaptic consequences on striatal neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032895     DOI: 10.1046/j.1471-4159.2000.0752061.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Effects of withdrawal from chronic escalating-dose binge cocaine on conditioned place preference to cocaine and striatal preproenkephalin mRNA in C57BL/6J mice.

Authors:  Yong Zhang; Stefan D Schlussman; Eduardo R Butelman; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropharmacology       Date:  2012-04-04       Impact factor: 5.250

2.  Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum.

Authors:  Raffaella Isola; Hailin Zhang; Gopi A Tejwani; Norton H Neff; Maria Hadjiconstantinou
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

3.  Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone.

Authors:  Chi-Tso Chiu; Tangeng Ma; Ing K Ho
Journal:  Brain Res Bull       Date:  2005-09-30       Impact factor: 4.077

4.  Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.

Authors:  A Crocker; R A España; M Papadopoulou; C B Saper; J Faraco; T Sakurai; M Honda; E Mignot; T E Scammell
Journal:  Neurology       Date:  2005-09-14       Impact factor: 9.910

5.  U-69593, a kappa opioid receptor agonist, decreases cocaine-induced behavioral sensitization in female rats.

Authors:  Anabel Puig-Ramos; Gladys S Santiago; Annabell C Segarra
Journal:  Behav Neurosci       Date:  2008-02       Impact factor: 1.912

6.  Cocaine-induced mu opioid receptor occupancy within the striatum is mediated by dopamine D2 receptors.

Authors:  Avery R Soderman; Ellen M Unterwald
Journal:  Brain Res       Date:  2009-08-20       Impact factor: 3.252

7.  Differential time course of effects of kappa-opioid agonist treatment on dynorphin A levels and kappa-opioid receptor density.

Authors:  Claudio D'Addario; Manuela Di Benedetto; Sari Izenwasser; Sanzio Candeletti; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.

Authors:  Melissa L Perreault; Dawn Graham; Sarah Scattolon; Yufang Wang; Henry Szechtman; Jane A Foster
Journal:  Psychopharmacology (Berl)       Date:  2007-07-10       Impact factor: 4.530

Review 9.  The role of enkephalinergic systems in substance use disorders.

Authors:  Lauren G Rysztak; Emily M Jutkiewicz
Journal:  Front Syst Neurosci       Date:  2022-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.